TheBioTechReview

Therapeutics

Exploring the latest in Therapeutics.

Beyond the $1.4B Price Tag: How AbbVie’s North Carolina Mega-Campus Reshapes the Sterile Injectable Supply Chain
Therapeutics

Beyond the $1.4B Price Tag: How AbbVie’s North Carolina Mega-Campus Reshapes the Sterile Injectable Supply Chain

Eli Lilly’s Kelonia Acquisition: Rewriting the Economics of In Vivo CAR-T Therapy
Therapeutics

Eli Lilly’s Kelonia Acquisition: Rewriting the Economics of In Vivo CAR-T Therapy

Beyond the 65% Surge: How Nektar's Rezpegaldesleukin Could Reshape the Alopecia Areata Treatment Paradigm
Therapeutics

Beyond the 65% Surge: How Nektar's Rezpegaldesleukin Could Reshape the Alopecia Areata Treatment Paradigm

Beyond the Headline: RFK Jr.'s HHS Defense and the Politics of Agency Budget Cuts
Therapeutics

Beyond the Headline: RFK Jr.'s HHS Defense and the Politics of Agency Budget Cuts

Content Moderation in the Digital Age: Navigating the 'Error' and the Unseen Filters
Therapeutics

Content Moderation in the Digital Age: Navigating the 'Error' and the Unseen Filters

Beyond mRNA and Gene Therapy: How Serif's 'Modified DNA' Aims to Redefine Biotech's Next Frontier
Therapeutics

Beyond mRNA and Gene Therapy: How Serif's 'Modified DNA' Aims to Redefine Biotech's Next Frontier